Related Experiment Videos
Vimentin expression in cervical carcinomas: association with invasive and migratory potential
C Gilles1, M Polette, J Piette
1Laboratory of General Biology, University of Liège, C.H.U. Sart-Tilman, Belgium.
The Journal of Pathology
|October 1, 1996
Summary
Aberrant vimentin expression in epithelial cancer cells correlates with invasiveness and metastasis. This study found vimentin in cervical carcinomas and lymph node metastases, but not in pre-cancerous lesions, supporting its role in cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Pathology
Background:
- Vimentin, an intermediate filament protein, is typically found in mesenchymal cells.
- Aberrant vimentin expression in epithelial cancers is increasingly linked to invasiveness and metastatic potential.
- Previous in vitro studies suggested a role for vimentin in the invasive properties of HPV-33-transformed cervical keratinocytes.
Purpose of the Study:
- To investigate the in vivo expression of vimentin in cervical neoplasms of varying grades.
- To correlate vimentin expression with metastatic progression in cervical cancer.
- To compare in vivo findings with existing in vitro data on cervical keratinocyte cell lines.
Main Methods:
- Immunohistochemistry was employed to detect vimentin expression.
- Cervical neoplasms of different grades were analyzed.
- In vitro invasiveness data from cervical keratinocyte cell lines were utilized for comparison.
Main Results:
- Vimentin expression was detected in all invasive cervical carcinomas and lymph node metastases examined.
- Vimentin was notably absent in CIN III (cervical intraepithelial neoplasia grade 3) lesions.
- In vitro invasiveness of cervical keratinocyte cell lines correlated with vimentin expression.
Conclusions:
- Vimentin expression is strongly associated with metastatic progression in cervical cancer.
- The in vivo findings support and emphasize the in vitro observations regarding vimentin's role in invasiveness.
- Vimentin may serve as a potential biomarker for predicting metastatic potential in cervical neoplasms.